Evaluation of the Completeness of ALS Case Ascertainment in the U.S. National ALS Registry: Application of the Capture-Recapture Method

Publication
Affiliates	Lorene Nelson [1], Barbara Topol [1], Wendy Kaye [2] , Jaime Raymond [3], D. Kevin Horton [3], Paul Mehta [3], Todd Wagner [4] [1] Department of Epidemiology and Population Health, Stanford University School of Medicine [2] McKing Consulting Corporation [3] Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention [4] Department of Surgery, Stanford University School of Medicine
Journal	Neuroepidemiology
Summary	The Centers for Disease Control and Prevention (CDC) National Amyotrophic Lateral Sclerosis (ALS) Registry is the first national registry for a chronic neurologic disease in the U.S. and uses a combination of case finding methods including administrative healthcare data and patient self-registration. Analysis shows that the methods used by the National ALS Registry provide for an excellent methodological foundation for estimating ALS prevalence in a large country with fragmented healthcare, and can be used for tracking prevalence of other neurological diseases.
Link to paper	Read the paper hereexternal icon!

Page last reviewed: November 18, 2021